Drug intelligence / Profile preview

celecoxib + acetaminophen + dexamethasone

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

A combination of three distinct medications that may be used together for pain management, particularly for acute pain and inflammatory conditions. While they're not formulated as a single product, they can be prescribed together as a multi-drug regimen. Celecoxib (Celebrex) is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). Acetaminophen (Tylenol) is a non-NSAID pain reliever. Dexamethasone is a corticosteroid used to treat various inflammatory conditions. The combination of these medications may provide enhanced pain relief through different mechanisms of action. Celecoxib and dexamethasone have been studied together for postoperative pain management, with both showing effectiveness. Additionally, celecoxib and acetaminophen can be safely used together, potentially allowing for lower doses of each medication and increased safety. When used in combination, these medications target pain and inflammation through different pathways: - Celecoxib selectively inhibits COX-2 enzymes - Acetaminophen has a different mechanism than NSAIDs - Dexamethasone reduces inflammation through corticosteroid action

02

Targets

GR (Glucocorticoid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on celecoxib + acetaminophen + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on celecoxib + acetaminophen + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call